Your Search Currently Includes:
	Project Type	=	Clinical Trial
	Year	=	Currently Active
	Type of Research	=	Prevention
	Type of Cancer	=	Breast Cancer

Add Criteria to Narrow Your Search To save items to a common list, check each desired item, then click the Add to My List button.	Display Options: Abstract List Summary		Excel Spreadsheet Text HTML

9 item(s) shown

# Title  Sort Principal Investigator  Sort State    Sort Institution  Sort Fund Mech,  Sort Project ID  Sort 1. Clinical Trial - Randomized Chemoprevention Study of Bexarotene in Women at High Genetic Risk for Breast Cancer 2. Clinical Trial - Phase II Chemoprevention Study of Celecoxib in Premenopausal Women at High Risk For Estrogen Receptor-Negative Breast Cancer 3. Clinical Trial - Phase II Randomized Study of Polyphenon E (Green Tea Extract) and Low-Dose Aspirin in Women at High Risk For Developing Breast Cancer 4. Clinical Trial - Phase I Study of the Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or at High Risk for Breast Cancer 5. Clinical Trial - Phase II Pilot Chemoprevention Study of Deslorelin in Combination With Low-Dose Add-Back Estradiol and Testosterone in Premenopausal Women With or Without a BRCA Gene Mutation Who Are at High Risk for Breast Cancer 6. Clinical Trial - Phase II Study of Ductal Lavage in Women With Early Breast Cancer Or With High Risk For Developing Breast Cancer Who Are Eligible For Tamoxifen Therapy 7. Clinical Trial - Phase II Study of Exemestane Alone or in Combination With Celecoxib in Postmenopausal Women at High Risk for Invasive Breast Cancer 8. Clinical Trial - Phase II Randomized Study of Celecoxib in Premenopausal Women at High Risk for Developing Breast Cancer 9. Clinical Trial - Phase III Randomized Study of Medroxyprogesterone Acetate Versus Observation for Prevention of Endometrial Pathology in Postmenopausal Women With Breast Cancer Treated With Adjuvant Tamoxifen

9 item(s) shown

---

Add Criteria to Narrow Your Search

Research Portfolio Home | Dictionary | Site Map | Privacy Policy | Accessibility | Contact Us